US Zamto-cel Autoimmune Diseases

Clinical trial NCT06708845 · RECRUITING

Trial details

NCT number: NCT06708845
Sponsor: Miltenyi Biomedicine GmbH
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lupus Nephritis Systemic Lupus Erythematosus Systemic Sclerosis (SSc)Diffuse Cutaneous Systemic Sclerosis

Start date: 2026-07-01
Primary completion: 2028-01-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.